Boston Scientific


 

ATLAS and the Weight of Experience

558 views
August 24, 2022

Dr. Jeff Healey and Professor Pier  Lambiase discuss the results of the ATLAS  trial, evaluating and comparing the lead related complications between TV-ICD and  EMBLEM S-ICD patients, and key  secondary endpoints including inappropriate shocks.

Comments 0
Login to view comments. Click here to Login